TACC2 and chronic obstructive pulmonary disease: Using Sanger sequencing, we validated all nonsense and non-synonymous TACC2 variants where the DNA samples were available, for a total of seven variants in eight COPD samples, including four novel variants (Additional file 7: Table S1).